Basic Information
SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100UNITS/ML + 50MCG/ML
INJECTION, SOLUTION
Regulatory Information
SIN15540P
September 20, 2018
Prescription Only
Therapeutic
SUBCUTANEOUS
August 10, 2023
May 30, 2025
XA10AE54
Company Information
Active Ingredients
Strength: 50 μg/mL
Strength: 100 units/ml
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**4.1 Therapeutic indications** Soliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors. (For study results with respect to effect on glycaemic control, and the populations studied, see section 4.4 and 5.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).